Category

Archives

Drug-Linker Conjugates for ADC

Advances in the treatment of metastatic prostate cancer

31 views | Dec 20 2023

The unprecedented therapeutic advances in metastatic prostate cancer, including recent approvals of triplet therapy regimens and novel agents, pose challenges in treatment selection and sequencing, emphasizing the need for a multidisciplinary approach informed by ongoing clinical trials and personalized medicine principles. [Read the Full Post]